Generics 麻豆原创 Summary, Competitive Analysis and Forecast to 2027 (Global Almanac)
Summary
Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
- 麻豆原创 volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
- Regional volumes are calculated as weighted averages of countries that comprise the region where volume data exists.
- All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2022 annual average exchange rates.
- The global generics market had total revenues of $336.9 billion in 2022, representing a compound annual growth rate (CAGR) of 7.2% between 2017 and 2022.
- 麻豆原创 consumption volume increased with a CAGR of 1.8% between 2017 and 2022, to reach a total of 40.1% in 2022.
- In 2022, the growth of the global generics market decelerated, witnessing an annual growth of 7.2% due to the reduction in generic drug prices.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
- Leading company profiles reveal details of key generics market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the global generics market by value in 2022?
- What will be the size of the global generics market in 2027?
- What factors are affecting the strength of competition in the global generics market?
- How has the market performed over the last five years?
- How large is the global generics market in relation to its regional counterparts?
Table of Contents
1 EXECUTIVE SUMMARY
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. 麻豆原创 volume
1.4. 麻豆原创 volume forecast
1.5. Geography segmentation
1.6. Competitive landscape
2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 Global Generics
3.1. 麻豆原创 Overview
3.2. 麻豆原创 Data
3.3. 麻豆原创 Segmentation
3.4. 麻豆原创 outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Generics in Asia-Pacific
5.1. 麻豆原创 Overview
5.2. 麻豆原创 Data
5.3. 麻豆原创 Segmentation
5.4. 麻豆原创 outlook
5.5. Five forces analysis
6 Generics in Europe
6.1. 麻豆原创 Overview
6.2. 麻豆原创 Data
6.3. 麻豆原创 Segmentation
6.4. 麻豆原创 outlook
6.5. Five forces analysis
7 Macroeconomic Indicators
7.1. Country data
8 Generics in France
8.1. 麻豆原创 Overview
8.2. 麻豆原创 Data
8.3. 麻豆原创 Segmentation
8.4. 麻豆原创 outlook
8.5. Five forces analysis
9 Macroeconomic Indicators
9.1. Country data
10 Generics in Germany
10.1. 麻豆原创 Overview
10.2. 麻豆原创 Data
10.3. 麻豆原创 Segmentation
10.4. 麻豆原创 outlook
10.5. Five forces analysis
11 Macroeconomic Indicators
11.1. Country data
12 Generics in Australia
12.1. 麻豆原创 Overview
12.2. 麻豆原创 Data
12.3. 麻豆原创 Segmentation
12.4. 麻豆原创 outlook
12.5. Five forces analysis
13 Macroeconomic Indicators
13.1. Country data
14 Generics in Brazil
14.1. 麻豆原创 Overview
14.2. 麻豆原创 Data
14.3. 麻豆原创 Segmentation
14.4. 麻豆原创 outlook
14.5. Five forces analysis
15 Macroeconomic Indicators
15.1. Country data
16 Generics in Canada
16.1. 麻豆原创 Overview
16.2. 麻豆原创 Data
16.3. 麻豆原创 Segmentation
16.4. 麻豆原创 outlook
16.5. Five forces analysis
17 Macroeconomic Indicators
17.1. Country data
18 Generics in China
18.1. 麻豆原创 Overview
18.2. 麻豆原创 Data
18.3. 麻豆原创 Segmentation
18.4. 麻豆原创 outlook
18.5. Five forces analysis
19 Macroeconomic Indicators
19.1. Country data
20 Generics in India
20.1. 麻豆原创 Overview
20.2. 麻豆原创 Data
20.3. 麻豆原创 Segmentation
20.4. 麻豆原创 outlook
20.5. Five forces analysis
21 Macroeconomic Indicators
21.1. Country data
22 Generics in Indonesia
22.1. 麻豆原创 Overview
22.2. 麻豆原创 Data
22.3. 麻豆原创 Segmentation
22.4. 麻豆原创 outlook
22.5. Five forces analysis
23 Macroeconomic Indicators
23.1. Country data
24 Generics in Italy
24.1. 麻豆原创 Overview
24.2. 麻豆原创 Data
24.3. 麻豆原创 Segmentation
24.4. 麻豆原创 outlook
24.5. Five forces analysis
25 Macroeconomic Indicators
25.1. Country data
26 Generics in Japan
26.1. 麻豆原创 Overview
26.2. 麻豆原创 Data
26.3. 麻豆原创 Segmentation
26.4. 麻豆原创 outlook
26.5. Five forces analysis
27 Macroeconomic Indicators
27.1. Country data
28 Generics in Mexico
28.1. 麻豆原创 Overview
28.2. 麻豆原创 Data
28.3. 麻豆原创 Segmentation
28.4. 麻豆原创 outlook
28.5. Five forces analysis
29 Macroeconomic Indicators
29.1. Country data
30 Generics in The Netherlands
30.1. 麻豆原创 Overview
30.2. 麻豆原创 Data
30.3. 麻豆原创 Segmentation
30.4. 麻豆原创 outlook
30.5. Five forces analysis
31 Macroeconomic Indicators
31.1. Country data
32 Generics in North America
32.1. 麻豆原创 Overview
32.2. 麻豆原创 Data
32.3. 麻豆原创 Segmentation
32.4. 麻豆原创 outlook
32.5. Five forces analysis
33 Generics in Russia
33.1. 麻豆原创 Overview
33.2. 麻豆原创 Data
33.3. 麻豆原创 Segmentation
33.4. 麻豆原创 outlook
33.5. Five forces analysis
34 Macroeconomic Indicators
34.1. Country data
35 Generics in Scandinavia
35.1. 麻豆原创 Overview
35.2. 麻豆原创 Data
35.3. 麻豆原创 Segmentation
35.4. 麻豆原创 outlook
35.5. Five forces analysis
36 Generics in Singapore
36.1. 麻豆原创 Overview
36.2. 麻豆原创 Data
36.3. 麻豆原创 Segmentation
36.4. 麻豆原创 outlook
36.5. Five forces analysis
37 Macroeconomic Indicators
37.1. Country data
38 Generics in South Africa
38.1. 麻豆原创 Overview
38.2. 麻豆原创 Data
38.3. 麻豆原创 Segmentation
38.4. 麻豆原创 outlook
38.5. Five forces analysis
39 Macroeconomic Indicators
39.1. Country data
40 Generics in South Korea
40.1. 麻豆原创 Overview
40.2. 麻豆原创 Data
40.3. 麻豆原创 Segmentation
40.4. 麻豆原创 outlook
40.5. Five forces analysis
41 Macroeconomic Indicators
41.1. Country data
42 Generics in Spain
42.1. 麻豆原创 Overview
42.2. 麻豆原创 Data
42.3. 麻豆原创 Segmentation
42.4. 麻豆原创 outlook
42.5. Five forces analysis
43 Macroeconomic Indicators
43.1. Country data
44 Generics in Turkey
44.1. 麻豆原创 Overview
44.2. 麻豆原创 Data
44.3. 麻豆原创 Segmentation
44.4. 麻豆原创 outlook
44.5. Five forces analysis
45 Macroeconomic Indicators
45.1. Country data
46 Generics in The United Kingdom
46.1. 麻豆原创 Overview
46.2. 麻豆原创 Data
46.3. 麻豆原创 Segmentation
46.4. 麻豆原创 outlook
46.5. Five forces analysis
47 Macroeconomic Indicators
47.1. Country data
48 Generics in The United States
48.1. 麻豆原创 Overview
48.2. 麻豆原创 Data
48.3. 麻豆原创 Segmentation
48.4. 麻豆原创 outlook
48.5. Five forces analysis
49 Macroeconomic Indicators
49.1. Country data
50 Company Profiles
50.1. Teva Pharmaceutical Industries Limited
50.2. Pfizer Inc.
50.3. Sun Pharmaceutical Industries Ltd
50.4. Viatris Inc.
50.5. Sanofi SA
50.6. Les Laboratoires Servier
50.7. STADA Arzneimittel AG
50.8. Novartis AG
50.9. Lupin Ltd
50.10. Aspen Pharmacare Holdings Ltd
50.11. EMS SA
50.12. Ache Laboratorios Farmaceuticos SA
50.13. Eurofarma Laboratorios SA
50.14. Apotex, Inc.
50.15. Grand Pharmaceutical Group Limited
50.16. Aurobindo Pharma Ltd
50.17. Cipla Limited
50.18. PT Kalbe Farma Tbk
50.19. PT Sanbe Farma
50.20. PT Soho Global Health Tbk
50.21. PT Indofarma (Persero), Tbk
50.22. Daiichi Sankyo Co Ltd
50.23. Sawai Pharmaceutical Co Ltd
50.24. Krka, d. d., Novo mesto
50.25. Abbott Laboratories
50.26. Adcock Ingram Holdings Ltd
50.27. Yuhan Corp
50.28. Esteve Group
50.29. Deva Holding AS
50.30. Nobelpharma Co Ltd
50.31. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
51 Appendix
51.1. Methodology
51.2. About 麻豆原创Line
List of Tables
Table 1: Global generics market value: $ million, 2017-22
Table 2: Global generics market volume: %, 2017-22
Table 3: Global generics market geography segmentation: $ million, 2022
Table 4: Global generics market value forecast: $ million, 2022-27
Table 5: Global generics market volume forecast: %, 2022-27
Table 6: Global size of population (million), 2018-22
Table 7: Global gdp (constant 2005 prices, $ billion), 2018-22
Table 8: Global gdp (current prices, $ billion), 2018-22
Table 9: Global inflation, 2018-22
Table 10: Global consumer price index (absolute), 2018-22
Table 11: Global exchange rate, 2018-22
Table 12: Asia-Pacific generics market value: $ million, 2017-22
Table 13: Asia-Pacific generics market volume: %, 2017-22
Table 14: Asia-Pacific generics market geography segmentation: $ million, 2022
Table 15: Asia-Pacific generics market value forecast: $ million, 2022-27
Table 16: Asia-Pacific generics market volume forecast: %, 2022-27
Table 17: Europe generics market value: $ million, 2017-22
Table 18: Europe generics market volume: %, 2017-22
Table 19: Europe generics market geography segmentation: $ million, 2022
Table 20: Europe generics market value forecast: $ million, 2022-27
Table 21: Europe generics market volume forecast: %, 2022-27
Table 22: Europe size of population (million), 2018-22
Table 23: Europe gdp (constant 2005 prices, $ billion), 2018-22
Table 24: Europe gdp (current prices, $ billion), 2018-22
Table 25: Europe inflation, 2018-22
Table 26: Europe consumer price index (absolute), 2018-22
Table 27: Europe exchange rate, 2018-22
Table 28: France generics market value: $ million, 2017-22
Table 29: France generics market volume: %, 2017-22
Table 30: France generics market geography segmentation: $ million, 2022
Table 31: France generics market value forecast: $ million, 2022-27
Table 32: France generics market volume forecast: %, 2022-27
Table 33: France size of population (million), 2018-22
Table 34: France gdp (constant 2005 prices, $ billion), 2018-22
Table 35: France gdp (current prices, $ billion), 2018-22
Table 36: France inflation, 2018-22
Table 37: France consumer price index (absolute), 2018-22
Table 38: France exchange rate, 2018-22
Table 39: Germany generics market value: $ million, 2017-22
Table 40: Germany generics market volume: %, 2017-22
Table 41: Germany generics market geography segmentation: $ million, 2022
Table 42: Germany generics market value forecast: $ million, 2022-27
Table 43: Germany generics market volume forecast: %, 2022-27
Table 44: Germany size of population (million), 2018-22
Table 45: Germany gdp (constant 2005 prices, $ billion), 2018-22
Table 46: Germany gdp (current prices, $ billion), 2018-22
Table 47: Germany inflation, 2018-22
Table 48: Germany consumer price index (absolute), 2018-22
Table 49: Germany exchange rate, 2018-22
Table 50: Australia generics market value: $ million, 2017-22
Table 51: Australia generics market volume: %, 2017-22
Table 52: Australia generics market geography segmentation: $ million, 2022
Table 53: Australia generics market value forecast: $ million, 2022-27
Table 54: Australia generics market volume forecast: %, 2022-27
Table 55: Australia size of population (million), 2018-22
Table 56: Australia gdp (constant 2005 prices, $ billion), 2018-22
Table 57: Australia gdp (current prices, $ billion), 2018-22
Table 58: Australia inflation, 2018-22
Table 59: Australia consumer price index (absolute), 2018-22
Table 60: Australia exchange rate, 2018-22
Table 61: Brazil generics market value: $ million, 2017-22
Table 62: Brazil generics market volume: %, 2017-22
Table 63: Brazil generics market geography segmentation: $ million, 2022
Table 64: Brazil generics market value forecast: $ million, 2022-27
Table 65: Brazil generics market volume forecast: %, 2022-27
Table 66: Brazil size of population (million), 2018-22
Table 67: Brazil gdp (constant 2005 prices, $ billion), 2018-22
Table 68: Brazil gdp (current prices, $ billion), 2018-22
Table 69: Brazil inflation, 2018-22
Table 70: Brazil consumer price index (absolute), 2018-22
Table 71: Brazil exchange rate, 2018-22
Table 72: Canada generics market value: $ million, 2017-22
Table 73: Canada generics market volume: %, 2017-22
Table 74: Canada generics market geography segmentation: $ million, 2022
Table 75: Canada generics market value forecast: $ million, 2022-27
Table 76: Canada generics market volume forecast: %, 2022-27
Table 77: Canada size of population (million), 2018-22
Table 78: Canada gdp (constant 2005 prices, $ billion), 2018-22
Table 79: Canada gdp (current prices, $ billion), 2018-22
Table 80: Canada inflation, 2018-22
Table 81: Canada consumer price index (absolute), 2018-22
Table 82: Canada exchange rate, 2018-22
Table 83: China generics market value: $ million, 2017-22
Table 84: China generics market volume: %, 2017-22
Table 85: China generics market geography segmentation: $ million, 2022
Table 86: China generics market value forecast: $ million, 2022-27
Table 87: China generics market volume forecast: %, 2022-27
Table 88: China size of population (million), 2018-22
Table 89: China gdp (constant 2005 prices, $ billion), 2018-22
Table 90: China gdp (current prices, $ billion), 2018-22
Table 91: China inflation, 2018-22
Table 92: China consumer price index (absolute), 2018-22
Table 93: China exchange rate, 2018-22
Table 94: India generics market value: $ million, 2017-22
Table 95: India generics market volume: %, 2017-22
Table 96: India generics market geography segmentation: $ million, 2022
Table 97: India generics market value forecast: $ million, 2022-27
Table 98: India generics market volume forecast: %, 2022-27
List of Figures
Figure 1: Global generics market value: $ million, 2017-22
Figure 2: Global generics market volume: %, 2017-22
Figure 3: Global generics market geography segmentation: % share, by value, 2022
Figure 4: Global generics market value forecast: $ million, 2022-27
Figure 5: Global generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the global generics market, 2022
Figure 7: Drivers of buyer power in the global generics market, 2022
Figure 8: Drivers of supplier power in the global generics market, 2022
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2022
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2022
Figure 11: Drivers of degree of rivalry in the global generics market, 2022
Figure 12: Asia-Pacific generics market value: $ million, 2017-22
Figure 13: Asia-Pacific generics market volume: %, 2017-22
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2022
Figure 15: Asia-Pacific generics market value forecast: $ million, 2022-27
Figure 16: Asia-Pacific generics market volume forecast: %, 2022-27
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2022
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2022
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2022
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2022
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2022
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2022
Figure 23: Europe generics market value: $ million, 2017-22
Figure 24: Europe generics market volume: %, 2017-22
Figure 25: Europe generics market geography segmentation: % share, by value, 2022
Figure 26: Europe generics market value forecast: $ million, 2022-27
Figure 27: Europe generics market volume forecast: %, 2022-27
Figure 28: Forces driving competition in the generics market in Europe, 2022
Figure 29: Drivers of buyer power in the generics market in Europe, 2022
Figure 30: Drivers of supplier power in the generics market in Europe, 2022
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2022
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2022
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2022
Figure 34: France generics market value: $ million, 2017-22
Figure 35: France generics market volume: %, 2017-22
Figure 36: France generics market geography segmentation: % share, by value, 2022
Figure 37: France generics market value forecast: $ million, 2022-27
Figure 38: France generics market volume forecast: %, 2022-27
Figure 39: Forces driving competition in the generics market in France, 2022
Figure 40: Drivers of buyer power in the generics market in France, 2022
Figure 41: Drivers of supplier power in the generics market in France, 2022
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2022
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2022
Figure 44: Drivers of degree of rivalry in the generics market in France, 2022
Figure 45: Germany generics market value: $ million, 2017-22
Figure 46: Germany generics market volume: %, 2017-22
Figure 47: Germany generics market geography segmentation: % share, by value, 2022
Figure 48: Germany generics market value forecast: $ million, 2022-27
Figure 49: Germany generics market volume forecast: %, 2022-27
Figure 50: Forces driving competition in the generics market in Germany, 2022
Figure 51: Drivers of buyer power in the generics market in Germany, 2022
Figure 52: Drivers of supplier power in the generics market in Germany, 2022
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2022
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2022
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2022
Figure 56: Australia generics market value: $ million, 2017-22
Figure 57: Australia generics market volume: %, 2017-22
Figure 58: Australia generics market geography segmentation: % share, by value, 2022
Figure 59: Australia generics market value forecast: $ million, 2022-27
Figure 60: Australia generics market volume forecast: %, 2022-27
Figure 61: Forces driving competition in the generics market in Australia, 2022
Figure 62: Drivers of buyer power in the generics market in Australia, 2022
Figure 63: Drivers of supplier power in the generics market in Australia, 2022
Figure 64: Factors influencing the likelihood of new entrants in the generics market in Australia, 2022
Figure 65: Factors influencing the threat of substitutes in the generics market in Australia, 2022
Figure 66: Drivers of degree of rivalry in the generics market in Australia, 2022
Figure 67: Brazil generics market value: $ million, 2017-22
Figure 68: Brazil generics market volume: %, 2017-22
Figure 69: Brazil generics market geography segmentation: % share, by value, 2022
Figure 70: Brazil generics market value forecast: $ million, 2022-27
Figure 71: Brazil generics market volume forecast: %, 2022-27
Figure 72: Forces driving competition in the generics market in Brazil, 2022
Figure 73: Drivers of buyer power in the generics market in Brazil, 2022
Figure 74: Drivers of supplier power in the generics market in Brazil, 2022
Figure 75: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2022
Figure 76: Factors influencing the threat of substitutes in the generics market in Brazil, 2022
Figure 77: Drivers of degree of rivalry in the generics market in Brazil, 2022
Figure 78: Canada generics market value: $ million, 2017-22
Figure 79: Canada generics market volume: %, 2017-22
Figure 80: Canada generics market geography segmentation: % share, by value, 2022
Figure 81: Canada generics market value forecast: $ million, 2022-27
Figure 82: Canada generics market volume forecast: %, 2022-27
Figure 83: Forces driving competition in the generics market in Canada, 2022
Figure 84: Drivers of buyer power in the generics market in Canada, 2022
Figure 85: Drivers of supplier power in the generics market in Canada, 2022
Figure 86: Factors influencing the likelihood of new entrants in the generics market in Canada, 2022
Figure 87: Factors influencing the threat of substitutes in the generics market in Canada, 2022
Figure 88: Drivers of degree of rivalry in the generics market in Canada, 2022
Figure 89: China generics market value: $ million, 2017-22
Figure 90: China generics market volume: %, 2017-22
Figure 91: China generics market geography segmentation: % share, by value, 2022
Figure 92: China generics market value forecast: $ million, 2022-27
Figure 93: China generics market volume forecast: %, 2022-27
Figure 94: Forces driving competition in the generics market in China, 2022
Figure 95: Drivers of buyer power in the generics market in China, 2022
Teva Pharmaceutical Industries Limited
Pfizer Inc.
Sun Pharmaceutical Industries Ltd
Viatris Inc.
Sanofi SA
Les Laboratoires Servier
STADA Arzneimittel AG
Novartis AG
Lupin Ltd
Aspen Pharmacare Holdings Ltd
EMS SA
Ache Laboratorios Farmaceuticos SA
Eurofarma Laboratorios SA
Apotex, Inc.
Grand Pharmaceutical Group Limited
Aurobindo Pharma Ltd
Cipla Limited
PT Kalbe Farma Tbk
PT Sanbe Farma
PT Soho Global Health Tbk
PT Indofarma (Persero), Tbk
Daiichi Sankyo Co Ltd
Sawai Pharmaceutical Co Ltd
Krka, d. d., Novo mesto
Abbott Laboratories
Adcock Ingram Holdings Ltd
Yuhan Corp
Esteve Group
Deva Holding AS
Nobelpharma Co Ltd
Abdi Ibrahim Ilac Sanayi ve Ticaret AS
听
听
*If Applicable.